Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Pharma Worried By EMA’s Stricter Approach To New Active Substance Claims For Biologics
Jun 15 2023
•
By
Vibha Sharma
NAS status is important for companies to protect their drug from generic competition for several years • Source: Shutterstock
More from Europe
More from Geography